Eli Lilly (LLY)

Add to Watchlists
Create an Alert
59.97 +0.55  +0.93% NYSE Apr 16, 5:00PM BATS Real time Currency in USD

Eli Lilly Cash from Investing (Quarterly):

-1.232B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Eli Lilly Cash from Investing (Quarterly) Chart

Export Data
Save Image

Eli Lilly Historical Cash from Investing (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 -1.232B
Sept. 30, 2013 -943.80M
June 30, 2013 -1.252B
March 31, 2013 1.355B
Dec. 31, 2012 -1.662B
Sept. 30, 2012 -132.70M
June 30, 2012 -385.30M
March 31, 2012 -652.30M
Dec. 31, 2011 -1.877B
Sept. 30, 2011 -1.008B
June 30, 2011 -1.899B
March 31, 2011 -40.70M
Dec. 31, 2010 -1.564B
Sept. 30, 2010 -788.50M
June 30, 2010 -754.20M
March 31, 2010 -52.60M
Dec. 31, 2009 -254.30M
Sept. 30, 2009 67.70M
June 30, 2009 102.10M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Get data for
Advertisement

LLY Cash from Investing (Quarterly) Benchmarks

Companies
Pfizer 80.00M
Novartis -2.655B
GlaxoSmithKline 2.955B

LLY Cash from Investing (Quarterly) Range, Past 5 Years

Minimum -1.899B Jun 2011
Maximum 1.355B Mar 2013
Average -682.86M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.